The company’s financial trajectory reflects a deliberate transition phase. Perimeter posted approximately $503,000 in revenue for the second quarter of 2026, driven by recurring sales of consumables and maintenance services. This performance marks a significant recovery from the $385,000 recorded in the first quarter of the year. Operating expenses dropped to $3.1 million, a 28 percent reduction compared to the same period in 2025, contributing to a net loss of $2.6 million—an improvement over the $3.9 million loss reported a year prior.
Perimeter Medical Imaging AI Reports Q2 Gains Amid Claire Launch
Perimeter Medical Imaging AI narrowed its quarterly losses and scaled commercial operations as the company pivots from its legacy S-Series technology to the newly FDA-cleared Claire OCT system. The Toronto and Dallas-based firm reported a 31 percent sequential revenue increase for the period ending June 30, 2026.
CEO Adrian Mendes signaled that the company is shifting its focus toward the widespread adoption of its AI-enabled Claire device, which received its first commercial deployment at Intermountain Health. Following its April unveiling in Seattle, the company has begun replacing existing S-Series units with the next-generation Claire technology at top-tier hospitals. To support these infrastructure goals, Perimeter bolstered its liquidity through a series of capital raises, including a unit offering and the issuance of convertible debentures, leaving the company with approximately $6.4 million in cash as of June 30.
Comments (0)
No comments yet. Be the first!